Medifron DBT to raise 13 bln won via stock sale
All News
18:10 June 22, 2022
SEOUL, June 22 (Yonhap) -- Medifron DBT Co.on Wednesday announced that it will sell stocks to raise 13 billion won (US$10 million). The proceeds from the stock offering will be used primarily to finance its operations.
According to a regulatory filing, the company will issue some 8.66 million preferred shares at a price of 1,500 won per share. The stocks will be sold to the investors that the firm designated.
(END)
Keywords
Issue Keywords
Most Liked
-
(Yonhap Interview) BTS producer encourages anticipation for future messages from group
-
BLACKPINK star Jisoo tests positive for COVID-19, to miss world tour stop in Osaka
-
(URGENT) Seoul city sends alert to residents to prepare for evacuation after N. Korea's launch
-
(News Focus) From hip-hop idols to global superstars, BTS shatters records over decade
-
Seoul city sends alert to residents to prepare for possible evacuation after N. Korea's launch
Most Saved
-
(Yonhap Interview) BTS producer encourages anticipation for future messages from group
-
Fifty Fifty chart on Billboard Hot 100 for 10th week with 'Cupid'
-
BLACKPINK star Jisoo tests positive for COVID-19, to miss world tour stop in Osaka
-
(URGENT) Seoul city sends alert to residents to prepare for evacuation after N. Korea's launch
-
S. Korea slams N. Korea's planned satellite launch, warns of consequences
-
(Yonhap Interview) BTS producer encourages anticipation for future messages from group
-
(News Focus) From hip-hop idols to global superstars, BTS shatters records over decade
-
N. Korean leader's sister slams UNSC meeting on space rocket launch
-
(2nd LD) S. Korea, Japan agree to hold working-level talks to prevent repeat of 2018 maritime incident: Seoul's defense chief
-
(2nd LD) Baritone Kim Tae-han becomes 1st Asian male singer to win Queen Elisabeth Competition